Gevorg Yaghjyan: Overview of the Rapidly Evolving Landscape of SLE at the 6th International Yale Rheumatology Symposium
Gevorg Yaghjyan, Project Leader at Parexel, shared a post on LinkedIn:
“Attended the 6th International Yale Rheumatology Symposium: Future Directions in Lupus at Yale.
The program provided an excellent and timely overview of the rapidly evolving landscape of systemic lupus erythematosus, covering new therapeutic approaches, lupus nephritis management, emerging clinical trials, and innovative strategies such as targeted biologics and cellular therapies.
A strong emphasis was placed on how advances in immunology and translational research are shaping the future of lupus drug development, creating new opportunities for more precise, effective, and patient-centered treatments.
The history of lupus drug development begins with better diagnosis. One important figure was George J. Friou, a Yale-trained physician–scientist who helped establish fluorescent antibody testing for antinuclear antibodies (ANA).
His work in the 1950s helped transform lupus from a poorly understood clinical syndrome into a measurable autoimmune disease. Today, ANA testing remains central to lupus diagnosis, patient selection, and the design of modern lupus clinical trials.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026